AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

dsm-firmenich says Richard Ridinger has become chairman of its Board of Directors after shareholders approved the appointment at an Extraordinary General Meeting on Oct. 19, 2026. He succeeds Thomas Leysen, who has retired from the board, and has also been elected to the Compensation Committee.

dsm-firmenich has confirmed Richard Ridinger as chairman of its Board of Directors after shareholders approved the appointment at an Extraordinary General Meeting on October 19, 2026. Ridinger succeeds Thomas Leysen, who has retired from the board, as the company continues work on its long-term business strategy.

Before you orderOffer from Amazon

Get beauty and skincare favorites delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

The appointment took effect following the shareholder vote, according to the report by Global Cosmetics News, which cited dsm-firmenich as its source. Ridinger had served as an independent director since 2023. The company did not disclose the vote count or any conditions attached to the approval in the supplied announcement.

Ridinger has also been elected to the company’s Compensation Committee. The source describes his professional experience as spanning executive and board roles in pharmaceuticals, home and personal care, nutrition and health. It does not provide further details about his committee responsibilities or any changes to the committee’s membership.

The chairmanship follows an earlier succession announcement in August, the report says. Leysen’s retirement leaves Ridinger leading the board as dsm-firmenich pursues its strategy; the announcement does not describe a change to the company’s executive leadership or day-to-day management.

At a glance
announcementWhen: Approved October 19, 2026; appointment…
The developmentdsm-firmenich confirmed Richard Ridinger as board chairman after shareholders approved the appointment at an extraordinary meeting.

A New Chair for Strategy Oversight

The chairman leads the board’s work overseeing the company’s direction and governance, making the appointment relevant to investors, employees and customers who follow dsm-firmenich’s strategic execution. Ridinger brings experience across several sectors linked to the company’s activities, according to the source, but the announcement does not set out specific priorities he will introduce as chair.

The change is a board leadership succession, not a reported shift in the company’s operating strategy. dsm-firmenich says it is continuing to implement its long-term plan, with a stated focus on strategic execution, innovation and long-term shareholder value. The significance will depend on how the board oversees that work; no new targets, projects or financial forecasts were announced alongside Ridinger’s appointment.

Products Worth Considering

Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor

Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor

Philips Sonicare DiamondClean 9500 Electric Toothbrush, Black, with 3 Brush Heads

Philips Sonicare DiamondClean 9500 Electric Toothbrush, Black, with 3 Brush Heads

Garmin Forerunner 265S Running Smartwatch, 42mm, Whitestone/Neo Tropic

Garmin Forerunner 265S Running Smartwatch, 42mm, Whitestone/Neo Tropic

As an affiliate, we earn on qualifying purchases.

From August Succession Plan to Vote

The October appointment followed a succession announcement made in August 2026, according to Global Cosmetics News. Shareholders then considered the appointment at an Extraordinary General Meeting on October 19. The supplied report does not give the date of the August announcement or explain whether shareholders voted on any other matters at the meeting.

Ridinger joined the board as an independent director in 2023, before becoming chairman. He replaces Leysen, whose retirement is confirmed in the report. The source identifies dsm-firmenich as a major supplier of fragrance and beauty ingredients and links the governance transition to the company’s continuing strategic work; it provides no further detail on the board’s recent performance or the reasons for Leysen’s departure.

“The company confirmed the appointment of Richard Ridinger as Chairman of its Board of Directors.”

— dsm-firmenich, as cited by Global Cosmetics News

Details Beyond the Appointment

The available report does not state the shareholder vote tally, the precise effective date beyond approval on October 19, or whether Ridinger’s appointment carries any new board mandates beyond the chairmanship and his Compensation Committee election. It also gives no reason for Leysen’s retirement and no direct comments from either chairman.

The source describes the board’s strategic focus in broad terms but does not specify changes to priorities, milestones or expected business results under Ridinger. Those details should not be inferred from his appointment alone. Further information may appear in company disclosures or subsequent board communications.

Board Oversight After Approval

With shareholder approval recorded, Ridinger is set to lead the board as dsm-firmenich continues implementing its long-term strategy. The next relevant updates are likely to come through company announcements, governance disclosures and future reporting on strategic execution. The source material does not identify a scheduled board milestone or give a date for a further update.

Investors and other stakeholders can watch for details on the Compensation Committee’s composition and responsibilities, as well as any board statements that clarify priorities under the new chair. Until the company provides such information, the confirmed development is the leadership change itself, rather than a newly announced shift in policy or business plans.

Key Questions

Who is the new chairman of dsm-firmenich?

Richard Ridinger has been confirmed as chairman of the Board of Directors after shareholder approval on October 19, 2026.

Who did Ridinger replace?

He succeeds Thomas Leysen, who has retired from the board, according to the report.

What other board role will Ridinger hold?

Ridinger has also been elected to dsm-firmenich’s Compensation Committee. The source does not provide more detail on his committee duties.

How long has Ridinger served on the board?

He has been an independent director since 2023, according to the source report.

Did dsm-firmenich announce a change in strategy with the appointment?

No new strategy or business targets were reported. The company is described as continuing to implement its existing long-term business strategy.

Source: rss

Wellness content on this site is informational and not a substitute for professional medical guidance.
You May Also Like

L’Oréal Appoints North Asia CFO To Boards Of Key Chinese Manufacturing Subsidiaries

Pietro Andrea Brambilla replaces Guillaume Dauchy on the boards of two L’Oréal cosmetics manufacturing subsidiaries in China.

The ’70S Hair Trends Set To Be Huge This Season

Glamour UK highlights seven ’70s-inspired cuts and styles, from shags and Birkin bangs to disco curls and Farrah Fawcett flicks.

Exclusive: BeautyPro Acquires Supercover To Bolster Colour Cosmetics Offering

British beauty company BeautyPro has acquired foundation brand Supercover for an undisclosed sum and plans to relaunch it with a redesigned website.

Beauty Reigns Seeks First Stakes Win In G2 Gallant Bloom

Beauty Reigns seeks her first stakes victory in the upcoming G2 Gallant Bloom, marking a key milestone in her racing career amid rising interest.